-+ 0.00%
-+ 0.00%
-+ 0.00%

vTv Therapeutics Q1 EPS $(0.77) Beats $(0.92) Estimate

Benzinga·05/15/2025 20:13:10
Listen to the news
vTv Therapeutics (NASDAQ:VTVT) reported quarterly losses of $(0.77) per share which beat the analyst consensus estimate of $(0.92) by 16.3 percent. This is a 34.19 percent increase over losses of $(1.17) per share from the same period last year.